Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
sell

Abivax S.A. sell Snowman

Abivax S.A.
Start price
€30.50
28.06.21 / 50%
Target price
€25.00
28.06.22
Performance (%)
-16.39%
End price
€25.50
01.12.21
Summary
This prediction ended on 01.12.21 with a price of €25.50. The price of Abivax S.A. decreased from the start of the prediction. Compared to the start price this resulted in a performance of -16.39%. Snowman has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Abivax S.A. - - -
iShares Core DAX® -0.051% 4.829% 17.062%
iShares Nasdaq 100 1.659% 2.417% 38.705%
iShares Nikkei 225® 0.658% -2.173% 13.159%
iShares S&P 500 0.964% 2.547% 30.492%

According to Snowman what are the pros and cons of Abivax S.A. for the foreseeable future?

Pros
Future proof or reliable business model
Cons
Probably not worthwhile Investment
overvalued
Very low/no dividend yield expected
Little known brand
Below average Marketposition

Comments by Snowman for this prediction

In the thread Abivax S.A. diskutieren
Prediction Sell
Perf. (%) -16.39%
Target price 25.000
Change
Ends at

Sell mit Kursziel 25,0

Snowman 
0
Report Share
28.06.21
In the thread Trading Abivax S.A.
Prediction Sell
Perf. (%) -16.39%
Target price 25.000
Change
Ends at 28.06.22

Sell beendet

Snowman 
0
Report Share
01.12.21

Stopped prediction by Snowman for Abivax S.A.

buy
Abivax S.A.

Start price
Target price
Perf. (%)
€25.50
01.12.21
€28.00
01.12.22
-31.92%
20.05.22

Future proof or reliable business model
Probably not worthwhile Investment
overvalued
Very low/no dividend yield expected
Snowman 
01.12.21 50%